Deadline: February 25, 2024.

A new initiative to promote health equity, capacity-strengthening, and unique focused learning between African medical institutions and Stanford.

*Applications are now open for the first two cohorts of the Stanford African Scholars in Global Health (SASH) Program! Learn more on this page and scroll down to apply.*

This three-year program supports 24 mid-career physicians from African countries to travel to Stanford for a six-week period of time, gaining a specific skill set identified by the African scholars as a need to improve health outcomes at their academic institution. Physicians will then return to their home countries to conduct a year-long clinical improvement project focused on the skill set they identified. This inaugural program is led by the Stanford Center for Innovation in Global Health, in partnership with the Stanford Center for Medical Education, and funded by an independent educational grant from Pfizer.

PHASE

Stanford will host a total of 24 scholars across several cohorts during the 3-year program (between 2024-2027). Each fellowship consists of two phases: The first at Stanford; the second in the country of their home institution.

Phase 1

Each cohort of accepted scholars will begin their fellowship with six weeks at Stanford, where they will be appointed as Visiting Instructors. The program will be tailored to their interests and implementation project topics.

Scholars will observe in clinical settings at Stanford hospitals and clinics and engage in other learning activities, including meeting with Stanford experts and participating in lectures and simulation activities where appropriate.

Each scholar will have a Stanford Faculty mentor, who will advise and train them. To facilitate bi-directional learning, scholars will have the opportunity to earn Continuing Medical Education credit, give guest lectures and present to the Stanford community.

The scholar’s time at Stanford will foster quality improvement for their home institution, including but not limited to subspecialty knowledge, treatment and management of complex cases, and/or advanced medical technology. They will also observe different approaches to care, health systems management, and medical education, all designed to enhance the identified skillset needed at their home institution.

Phase 2

After training at Stanford, scholars will return to their academic institutions with a grant of up to $50,000 from Pfizer, provided directly to their institution, to implement their individual proposed project over the next 12-18 months. They will engage in virtual meetings with their Stanford mentors as appropriate, for continued support.  CIGH will hold a final convening (likely in East Africa) in Year 3 with all scholars where they will present on the impact that their projects have achieved.

ELIGIBILITY CRITERIA

This program is open to licensed African physicians with a faculty appointment, who are currently working at an African academic institution. It is open to physicians from all specialties and primary care who seek a specific skill to improve health outcomes at their institution. However, they will prioritize those from Sub-Saharan Africa interested in the fields of antimicrobial resistance, oncology, vaccine uptake or inflammatory diseases.

To be considered, applicants must meet all the following eligibility criteria:

• Be in good standing within their institutions and demonstrate an ongoing commitment to improving health outcomes in their home countries.
• Be an African citizen* who is currently living, teaching and practicing clinically in an African country.
• Be a board-certified medical doctor with one of the following degrees: MD, MBChB or MMed.
• Be a mid-career physician, appointed as a faculty member for at least 3 and less than 15 years.
• Have strong working proficiency in written and spoken English (as determined by the selection committee).

* This program is not open to United States-licensed Healthcare Professionals
*This program is only for physicians practicing in Africa and applicants may not reside, and their home institutions may not be located in a restricted market (includes the Crimean Peninsula, Cuba, the Donbass Region, Iran, North Korea, Sudan and Syria). Applicants cannot be listed on any restricted persons and entities list maintained by the US, EU, UN or other relevant government bodies.

BENEFITS

The program includes/provides:

• Visa costs
• Living expenses while at Stanford during Phase 1
• Honorarium for Phase 1
• Travel to and from a San Francisco regional airport, economy class roundtrip airfare for the awardee only, and associated travel costs to Stanford for Phase 1
• Up to $50,000 in grant funding from Pfizer provided directly to scholars’ academic institutions for phase 2 project implementation. These funds cannot be used to purchase capital equipment.*

Apply through the OFFICIAL LINK